Pregnancy Outcomes Following Hysteroscopic Expansion of the Uterine Cavity for Patients With Small Cavities and Poor Reproductive Outcomes
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 9
- Locations
- 1
- Primary Endpoint
- Ongoing pregnancy
Study Overview
Brief Summary
This study seeks to evaluate pregnancy outcomes following hysteroscopic uterine cavity expansion surgery for patients with dysmorphic uterine cavities and poor reproductive histories. Patients already planning to undergo surgery at the recommendation of their physicians will be recruited for participation.
Detailed Description
Any patient scheduled to undergo hysteroscopic expansion of the uterine cavity at RMANJ is eligible to participate in the study. Patients will be approached for consent to participate in the study prior to undergoing surgery. If enrolled, outcomes following surgery will be followed and recorded.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Any patient scheduled to undergo hysteroscopic expansion of the uterine cavity
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Ongoing pregnancy
Time Frame: 2 years
presence of a fetal heartbeat at 8 weeks gestation
Secondary Outcomes
- Chemical pregnancy(2 years)
- Ectopic pregnancy(2 years)
- Clinical pregnancy(2 years)
- Live birth(2 years)
- Obstetrical complications(2 years)
- Change in endometrial volume(1 month)
- Time to conceive(2 years)
- Pregnancy loss(2 years)
- Birthweight(2 years)
- Gestational age at delivery(2 years)
